Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Intel’s Buyback Is Brilliant Given Its Cheap Valuation

The Intel stock buyback move is brilliant, given its cheap valuation. It will allows the dividend per share to rise at no higher cost.

CureVac Is a Bet on a Safe and Effective Vaccine

CureVac is a bet on a winning Covid-19 vaccine that is effective and safe. Buying CureVac stock could produce a 27.5% annual compounded return over the next two years.

Whiting Petroleum Will Emerge From Bankruptcy Looking Weak

Whiting Petroleum will emerge from bankruptcy on Sept. 1 very weakened. Don't bother buying WLL stock until its future becomes clearer.

Square Stock Will Keep Rising as Cash App Drives Massive Growth

Square is likely to keep on rising as Cash App takes over its growth. SQ stock is likely to triple over the next three to four years, as Cash App pushes its valuation close to PayPal's.

Exxon Mobil’s Commitment To Its Dividend Is Pushing Its Yield Higher

Exxon's dividend commitment is pushing the yield higher. At an 8.5% dividend yield today, Exxon Mobil stock could keep falling anyway.